International Journal on Science and Technology

E-ISSN: 2229-7677     Impact Factor: 9.88

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 17 Issue 2 April-June 2026 Submit your research before last 3 days of June to publish your research paper in the issue of April-June.

Chemical and Biological Insights into Belactosin-based Proteasome Inhibitors

Author(s) K. Saritha Rani, Rafiya Sultana, G. Pranitha
Country India
Abstract Belactosin is a naturally occurring peptide-derived secondary metabolite isolated from Streptomyces species and is recognized for its potent proteasome inhibitory activity. The proteasome plays a crucial role in intracellular protein degradation and regulation of cell cycle, apoptosis, and immune responses. Inhibition of the proteasome has emerged as a validated therapeutic strategy, particularly in cancer treatment. Belactosin A and its analogues possess a unique β-lactone moiety responsible for irreversible binding to the catalytic threonine residue of the proteasome. This paper presents a comprehensive review of belactosin, covering its discovery, chemical structure, biosynthesis, mechanism of action, biological activities, structure–activity relationships, pharmaceutical relevance, and future prospects. The study highlights belactosin as an important lead compound in natural product–based drug discovery.
Keywords Belactosin, Proteasome Inhibitor, β-lactone, Streptomyces, Natural Products, Anticancer Agents
Published In Conference / Special Issue (Volume 17 | Issue 1) - One Day National Seminar on “Advances in Life Sciences for Diversity, Applications, and Human Welfare” (ALSDAHW-2025) (March 2026)
Published On 2026-03-16
DOI https://doi.org/10.71097/IJSAT.ALSDAHW-2025.105

Share this